Gunaydin, S. Et Al. 2023. Diffractaic acid exhibits thioredoxin reductase 1 inhibition in lung cancer A549 cells. JOURNAL OF APPLIED TOXICOLOGY , vol.43, no.11 , 1676-1685.

Gunaydin, S., Sulukoglu, E. K., Kalin, S. N., ALTAY, A., & BUDAK, H., (2023). Diffractaic acid exhibits thioredoxin reductase 1 inhibition in lung cancer A549 cells. JOURNAL OF APPLIED TOXICOLOGY , vol.43, no.11, 1676-1685.

Gunaydin, Sukran Et Al. "Diffractaic acid exhibits thioredoxin reductase 1 inhibition in lung cancer A549 cells," JOURNAL OF APPLIED TOXICOLOGY , vol.43, no.11, 1676-1685, 2023

Gunaydin, Sukran Et Al. "Diffractaic acid exhibits thioredoxin reductase 1 inhibition in lung cancer A549 cells." JOURNAL OF APPLIED TOXICOLOGY , vol.43, no.11, pp.1676-1685, 2023

Gunaydin, S. Et Al. (2023) . "Diffractaic acid exhibits thioredoxin reductase 1 inhibition in lung cancer A549 cells." JOURNAL OF APPLIED TOXICOLOGY , vol.43, no.11, pp.1676-1685.

@article{article, author={Sukran Gunaydin Et Al. }, title={Diffractaic acid exhibits thioredoxin reductase 1 inhibition in lung cancer A549 cells}, journal={JOURNAL OF APPLIED TOXICOLOGY}, year=2023, pages={1676-1685} }